1. Spontaneous coronary artery dissection in a young patient with antiphospholipid syndrome.
- Author
-
Ho, Ai Phi Thuy, Tjønnfjord, Eirik, Meyerdierks, Oliver, and Brodin, Ellen Elisabeth
- Subjects
WARFARIN ,ARTERIAL dissections ,PERCUTANEOUS coronary intervention ,COMBINATION drug therapy ,ANTIPHOSPHOLIPID syndrome ,SURGICAL stents ,PATIENT readmissions ,ST elevation myocardial infarction ,TREATMENT effectiveness ,PLATELET aggregation inhibitors ,CHEST pain ,ELECTROCARDIOGRAPHY ,CORONARY arteries ,INTERNATIONAL normalized ratio ,CARDIOVASCULAR disease diagnosis ,DISEASE complications ,SYMPTOMS - Abstract
A 28-year-old man diagnosed with triple positive antiphospholipid syndrome (APS) and undergoing warfarin experienced three separate admissions to the cardiac ward within a one-month period due to escalating chest pain. While the initial two admissions revealed normal results in cardiological investigations, such as blood tests, electrocardiogram, and echocardiography, the third admission unveiled signs of ST-elevation myocardial infarction (STEMI), despite the patient maintaining an INR (International Normalized Ratio) of 4. Subsequent percutaneous coronary intervention (PCI) exposed spontaneous coronary artery dissection (SCAD) of type 3. Faced with hemodynamic instability and worsening symptoms, the patient underwent stenting and was prescribed dual antiplatelet therapy in addition to warfarin. A follow-up evaluation one month later indicated a normalization of his condition. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF